Form 8-K - Current report:
SEC Accession No. 0001193125-21-347940
Filing Date
2021-12-03
Accepted
2021-12-03 16:53:39
Documents
13
Period of Report
2021-12-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d261776d8k.htm   iXBRL 8-K 25018
2 EX-99.1 d261776dex991.htm EX-99.1 4016
  Complete submission text file 0001193125-21-347940.txt   149333

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20211201.xsd EX-101.SCH 2886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20211201_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20211201_pre.xml EX-101.PRE 10949
6 EXTRACTED XBRL INSTANCE DOCUMENT d261776d8k_htm.xml XML 3262
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 211470750
SIC: 2835 In Vitro & In Vivo Diagnostic Substances